1 Product identity
Ingredient risk
Contains restricted ingredients
Sereni-Pro
BrandBioclinic Naturals→Botanical Capsule 11 ingredients 1 banned 1 caution DSLD #20872Net contents: 90 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-04-25
2 Ingredients (11)
IngredientGroupSafety
minimum 8% Withanolides——
EleutheroEleuthero—
0.8% EleutherosidesEleutheroside—
3.5% Rosavins——
1% SalidrosidesSalidroside—
Vegetarian capsulecapsule—
Rice powderRice—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
Lavender — Limited Evidence
⚠ GI effects (burping lavender taste)
⚠ Drowsiness
Rhodiola — Conditionally Safe
⚠ Insomnia if taken late
⚠ MAOI-like activity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID20872
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-04-25
6 More from Bioclinic Naturals
View Bioclinic Naturals Safety Scorecard → 37 products
AlkaCare pHB12BioFoundation-GBioLivXBioLivXCalm-Pro Tropical Breeze7 Cite this page
Vancouver
Pkhakadze G. Sereni-Pro — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 16]. Available from: https://supplement.ge/products/sereni-pro-20872/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG